当前位置:首页 - 行情中心 - 千红制药(002550) - 财务分析 - 现金流量表

千红制药

(002550)

  

流通市值:60.90亿  总市值:82.80亿
流通股本:9.41亿   总股本:12.80亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金432,825,600.521,704,076,524.071,277,800,881.7800,568,355.51
  收到的税费返还258,059.38-166,248.01166,248.01
  收到其他与经营活动有关的现金19,444,416.8231,293,035.3128,823,521.0619,008,921.38
  经营活动现金流入小计452,528,076.721,735,369,559.381,306,790,650.77819,743,524.9
  购买商品、接受劳务支付的现金152,629,339.64644,062,050.42521,798,617.19339,538,295.46
  支付给职工以及为职工支付的现金73,896,240.34212,059,651.55171,503,922.6123,639,900.86
  支付的各项税费30,574,817.04156,060,042.07111,197,617.867,622,749.53
  支付其他与经营活动有关的现金57,168,482.13361,826,362.22210,943,759.46143,106,397.61
  经营活动现金流出小计314,268,879.151,374,008,106.261,015,443,917.05673,907,343.46
  经营活动产生的现金流量净额138,259,197.57361,361,453.12291,346,733.72145,836,181.44
二、投资活动产生的现金流量:
  收回投资收到的现金-188,594,260.22--
  取得投资收益收到的现金6,402,504.5915,926,056.715,565,369.034,737,594.54
  处置固定资产、无形资产和其他长期资产收回的现金净额-90,131.2200
  收到的其他与投资活动有关的现金436,458,997.44142,234,492.651,260,610,787.43916,001,823.25
  投资活动现金流入小计442,861,502.03346,844,940.791,276,176,156.46920,739,417.79
  购建固定资产、无形资产和其他长期资产支付的现金45,818,795.09141,604,595.5976,287,965.8660,708,517.94
  投资支付的现金-45,905,638.89--
  支付其他与投资活动有关的现金390,250,599.78321,675,825.351,341,390,324.21679,853,000
  投资活动现金流出小计436,069,394.87509,186,059.831,417,678,290.07740,561,517.94
  投资活动产生的现金流量净额6,792,107.16-162,341,119.04-141,502,133.61180,177,899.85
三、筹资活动产生的现金流量:
  吸收投资收到的现金-24,500,00024,500,000-
  其中:子公司吸收少数股东投资收到的现金-24,500,00024,500,000-
  收到其他与筹资活动有关的现金46,126,3758,257,480--
  筹资活动现金流入平衡项目000-
  筹资活动现金流入小计46,126,37532,757,48024,500,000-
  偿还债务支付的现金-20,000,00020,000,000600,000
  分配股利、利润或偿付利息支付的现金-150,434,116.81150,929,352.81150,837,240.79
  支付其他与筹资活动有关的现金--00
  筹资活动现金流出平衡项目-000
  筹资活动现金流出小计-170,434,116.81170,929,352.81151,437,240.79
  筹资活动产生的现金流量净额46,126,375-137,676,636.81-146,429,352.81-151,437,240.79
四、汇率变动对现金及现金等价物的影响-1,915,895.88-13,051,061.63-4,075,986.45-1,137,744.46
五、现金及现金等价物净增加额189,261,783.8548,292,635.64-660,739.15173,439,096.04
  加:期初现金及现金等价物余额488,238,035.65439,945,400.01439,945,400.01439,945,400.01
  期末现金及现金等价物余额677,499,819.5488,238,035.65439,284,660.86613,384,496.05
补充资料:
  净利润-373,254,947.94-249,582,175.18
  资产减值准备--109,775,119.84--51,995,351.1
  固定资产和投资性房地产折旧-61,959,643.23-28,953,674.22
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-61,959,643.23-28,953,674.22
  无形资产摊销-3,748,884.62-1,860,339.43
  长期待摊费用摊销-3,907,896.92-1,927,044.3
  处置固定资产、无形资产和其他长期资产的损失--14,356.7--
  固定资产报废损失-96,718.91-29,737.73
  公允价值变动损失--6,548,550.29--2,768,482.85
  财务费用-14,580,788.7-2,211,042.83
  投资损失--11,592,371.35--5,025,058.69
  递延所得税-9,489,991.27-7,590,764.04
  其中:递延所得税资产减少-8,735,232.69-8,143,009.62
    递延所得税负债增加-754,758.58--552,245.58
  存货的减少-49,074,465.54-68,884,135.02
  经营性应收项目的减少--37,844,134.83--94,972,373.31
  经营性应付项目的增加-12,922,590.32--60,441,465.36
  其他--2,090,515.29--
  现金的期末余额-488,238,035.65-613,384,496.05
  减:现金的期初余额-439,945,400.01-439,945,400.01
  现金及现金等价物的净增加额-48,292,635.64-173,439,096.04
公告日期2026-04-242026-04-242025-10-302025-08-23
审计意见(境内)标准无保留意见
TOP↑